Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEZXN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,548
Award facts
- Contract value 100% obligated
- $1,548.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, issued on August 21, 2025. The contract involves no set-aside designation and represents a competitively awarded transaction under an open procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the delivery order from its corporate office location. BIKTARVY is an antiretroviral medication used in the treatment of HIV, reflecting the pharmaceutical supply chain requirements of the federal military and veteran healthcare systems that the DLA manages.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The DLA Troop Support is simultaneously establishing Pharmaceutical Prime Vendor Global Program Generation V contracts, with plans to make multiple awards for separate regions, positioning AmerisourceBergen Drug Corp as a critical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEZXN?
SPE2DB25FEZXN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FEZXN worth?
The government has obligated $1,548 on SPE2DB25FEZXN.
Is contract SPE2DB25FEZXN an order under another contract?
Yes. SPE2DB25FEZXN is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZXN competed?
The extent of competition for SPE2DB25FEZXN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award